BPC-157 directly stimulates fibroblast migration and collagen synthesis at the injury site
It is considered by researchers to be one of the most selective secretagogues and is an apparent agonist of the growth hormone/ghrelin secretagogue receptor
The real risk with irregular timing is missed doses
Besides the acute phase gastrointestinal effects which may lead to up to 10% of people discontinuing the drugs, there are other potential GI side effects of obstruction, excessive loss of muscle mass, and potentially association with some eye disease adverse events
Clear, colorless solution supplied in sealed vials
Sources Barrier BPC-GI product page InfiniWell BPC Rapid Pro product page InfiniWell BPC Delayed Pro product page InfiniWell BPC-Lx Pro product page Buckley et al.: gastric absorption of semaglutide co-formulated with SNAC Bkdal et al.: oral semaglutide tablet erosion and pharmacokinetics ClinicalTrials.gov: PCO-02 oral BPC-157 safety and pharmacokinetics trial He et al.: preclinical BPC-157 pharmacokinetics in rats and dogs FDA: BPC-157 and other bulk substances that may present safety risks FDA briefing document for the July 2324, 2026 PCAC meeting FDA guidance on dietary-supplement structure/function claims Referral link and coupon code If you choose to explore InfiniWell after reviewing the evidence and limitations above, PeptideBenchmarks disclosed referral link is: Visit InfiniWell through the disclosed referral link Current PeptideBenchmark coupon code: IW15 15% off The referral relationship does not affect the comparison, and the link should not be interpreted as medical guidance or a claim that the product is suitable for any individual.
